Cart
sales@molnova.com
Cyclosporine
CAS No. 79217-60-0
Cyclosporine( —— )
Catalog No. M19109 CAS No. 79217-60-0
Cyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 45 | In Stock |
|
| 50MG | 83 | In Stock |
|
| 100MG | 119 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 303 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclosporine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.
-
DescriptionCyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorcalcineurin phosphatase
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number79217-60-0
-
Formula Weight1202.61
-
Molecular FormulaC62H111N11O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL
-
SMILESCCC1NC(=O)C([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hojo M,etal.Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999 Feb 11;397(6719):530-4.
molnova catalog
related products
-
Bellidifolin
Bellidifolin shows the inhibition of monoamine oxidase activity.
-
NBD-Cl
NBD-Cl is a nonfluorescent compound that becomes highly fluorescent after reaction with amino or thiol groups.
-
SKI II
SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.
